Drugs / PediaBerry
last change May 2023 re-read 3 minutes ago

PediaBerry

Developed for
hemangioma
Investigated by
Gayle Gordillo · National Institute of General Medical Sciences (NIGMS) · National Institutes of Health (NIH)

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT04020419 Dec 2020 → May 2023 hemangioma Gayle Gordillo Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PediaBerry ClinicalTrials.gov intervention name — accepted as the source's own label NCT04020419 ↗
Route Oral “PediaBerry or placebo will be mixed with a cream vehicle for topical administration or with water for oral administration” NCT04020419 ↗
Route Topical “PediaBerry or placebo will be mixed with a cream vehicle for topical administration or with water for oral administration” NCT04020419 ↗